IQVIA™ Pharma Deals: PharmaDeals Review: Table of Contents

<< Previous Issue

Aug 2006 (Vol: 2006, Issue: 74)

Next Issue >>

Download pdf of entire issue

Section: Business Commentaries
The Culture of Deal Making Published: 1 Aug-2006
By: Fintan Walton
Abstract Fulltext:
Section: Cartoons
Due Diligence Published: 6 Aug-2006
Details
Section: Deal Trackers
Ceplene (histamine dihydrochloride) Published: 6 Aug-2006
By: Business Review Editor
Abstract Fulltext:
Section: Features
Medivir Refocuses its Pipeline via Tibotec Deals Published: 1 Aug-2006
By: Business Review Editor
Abstract Fulltext:
Diagnosing Change: Celera Genomics' Strategic Drug Sell-Off Published: 1 Aug-2006
By: Business Review Editor
Abstract Fulltext:
Deal Making Review: 2000-2005, with Projections for 2006 Published: 1 Aug-2006
By: Business Review Editor
Abstract Fulltext:
Therapy Focus: Atherosclerosis Published: 1 Aug-2006
By: Business Review Editor
Abstract Fulltext:
Section: General
Vertex Views Success on the Horizon Published: 6 Aug-2006
By: Business Review Editor
Abstract Fulltext:
CrystaX Pharmaceuticals SL Published: 6 Aug-2006
By: Business Review Editor
Abstract Fulltext:
Section: Licensing
Mayne Pays US$34 M for Rights to SuperGen Oncology Published: 6 Aug-2006
By: Business Review Editor
Abstract Fulltext:
Nastech and Amylin Sign Deal for Diabetes Nasal Spray Published: 6 Aug-2006
By: Business Review Editor
Abstract Fulltext:
Section: Mergers & Acquisitions
Barr and Actavis Battle for PLIVA Published: 6 Aug-2006
By: Business Review Editor
Abstract Fulltext:
Section: Research & Development
Mundipharma to Develop Sosei’s Fentanyl Pain Spray Published: 6 Aug-2006
By: Business Review Editor
Abstract Fulltext:
J&J Active on the Deal Front Published: 6 Aug-2006
By: Business Review Editor
Abstract Fulltext:

Login

Username:

Password:

Keep me logged in